BACKGROUND: The objective of this study was to estimate the incidence of invasive cervical cancer (ICC) in women with human immunodeficiency virus (HIV) and compare it with the incidence in HIV-uninfected women. METHODS: In a cohort study of HIV-infected and uninfected women who had Papanicolaou tests obtained every 6 months, pathology reports were retrieved for women who had biopsy results or a self-report of ICC. Histology was reviewed when reports confirmed ICC. Incidence rates were calculated and compared with those in HIV-negative women. RESULTS: After a median follow-up of 10.3 years, 3 ICCs were confirmed in HIV-seropositive women, and none were confirmed in HIV-seronegative women. The ICC incidence rate was not found to be associated significantly with HIV status (HIV-negative women [0 of 100,000 person-years] vs HIV-positive women [21.4 of 100,000 person-years]; P = .59). A calculated incidence rate ratio standardized to expected results from the Surveillance Epidemiology and End Results database that was restricted to HIV-infected Women's Interagency HIV Study participants was 1.32 (95% confidence interval, 0.27-3.85; P = 0.80). CONCLUSIONS: Among women with HIV in a prospective study that incorporated cervical cancer prevention measures, the incidence of ICC was not significantly higher than that in a comparison group of HIV-negative women. (c) 2008 American Cancer Society.
BACKGROUND: The objective of this study was to estimate the incidence of invasive cervical cancer (ICC) in women with human immunodeficiency virus (HIV) and compare it with the incidence in HIV-uninfectedwomen. METHODS: In a cohort study of HIV-infected and uninfected women who had Papanicolaou tests obtained every 6 months, pathology reports were retrieved for women who had biopsy results or a self-report of ICC. Histology was reviewed when reports confirmed ICC. Incidence rates were calculated and compared with those in HIV-negative women. RESULTS: After a median follow-up of 10.3 years, 3 ICCs were confirmed in HIV-seropositive women, and none were confirmed in HIV-seronegative women. The ICC incidence rate was not found to be associated significantly with HIV status (HIV-negative women [0 of 100,000 person-years] vs HIV-positive women [21.4 of 100,000 person-years]; P = .59). A calculated incidence rate ratio standardized to expected results from the Surveillance Epidemiology and End Results database that was restricted to HIV-infectedWomen's Interagency HIV Study participants was 1.32 (95% confidence interval, 0.27-3.85; P = 0.80). CONCLUSIONS: Among women with HIV in a prospective study that incorporated cervical cancer prevention measures, the incidence of ICC was not significantly higher than that in a comparison group of HIV-negative women. (c) 2008 American Cancer Society.
Authors: H E Cejtin; E Komaroff; L S Massad; A Korn; J B Schmidt; D Eisenberger-Matiyahu; E Stier Journal: J Acquir Immune Defic Syndr Date: 1999-11-01 Impact factor: 3.731
Authors: D Serraino; P Carrieri; C Pradier; E Bidoli; M Dorrucci; E Ghetti; A Schiesari; R Zucconi; P Pezzotti; P Dellamonica; S Franceschi; G Rezza Journal: Int J Cancer Date: 1999-07-30 Impact factor: 7.396
Authors: L S Massad; K A Riester; K M Anastos; R G Fruchter; J M Palefsky; R D Burk; D Burns; R M Greenblatt; L I Muderspach; P Miotti Journal: J Acquir Immune Defic Syndr Date: 1999-05-01 Impact factor: 3.731
Authors: L Stewart Massad; Eric C Seaberg; Rodney L Wright; Teresa Darragh; Yi-Chun Lee; Christine Colie; Robert Burk; Howard D Strickler; D Heather Watts Journal: Obstet Gynecol Date: 2008-06 Impact factor: 7.661
Authors: L Stewart Massad; Christopher B Pierce; Howard Minkoff; D Heather Watts; Teresa M Darragh; Lorraine Sanchez-Keeland; Rodney L Wright; Christine Colie; Gypsyamber D'Souza Journal: Int J Cancer Date: 2013-10-29 Impact factor: 7.396
Authors: Lauro Ferreira da Silva Pinto Neto; Maria da Conceição Milanez; Jonathan Eric Golub; Angelica Espinosa Barbosa Miranda Journal: Rev Soc Bras Med Trop Date: 2012-12 Impact factor: 1.581
Authors: L Stewart Massad; Xianhong Xie; Robert D Burk; Gypsyamber D'Souza; Teresa M Darragh; Howard Minkoff; Christine Colie; Pamela Burian; Joel Palefsky; Jessica Atrio; Howard D Strickler Journal: Am J Obstet Gynecol Date: 2015-11-14 Impact factor: 8.661
Authors: L Stewart Massad; Xianhong Xie; Gypsyamber D'Souza; Teresa M Darragh; Howard Minkoff; Rodney Wright; Christine Colie; Lorraine Sanchez-Keeland; Howard D Strickler Journal: Am J Obstet Gynecol Date: 2014-12-10 Impact factor: 8.661
Authors: Luigino Dal Maso; Silvia Franceschi; Mauro Lise; Priscilla Sassoli De' Bianchi; Jerry Polesel; Florio Ghinelli; Fabio Falcini; Alba C Finarelli Journal: BMC Cancer Date: 2010-06-21 Impact factor: 4.430
Authors: Nancy F Crum-Cianflone; Katherine Huppler Hullsiek; Vincent C Marconi; Anuradha Ganesan; Amy Weintrob; Robert V Barthel; Brian K Agan Journal: AIDS Date: 2010-02-20 Impact factor: 4.177